Assessment of the inter-individual variation observed between patients receiving HIV antiretroviral therapy
The WHO currently recommends tenofovir (TFV) disoproxil fumarate (TDF) or TFV alafenamide (TAF) as a preferred first-line antiretroviral therapy (ART) for the treatment and prevention of HIV. However, mild to moderate TFV-related renal toxicity is an uncommon but significant complication for TDF the...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Liverpool
2018
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.762815 |